SCHEMBL2560102

SCHEMBL2560102

O=Cc1ccc(O)c2oc3cnccc3c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 8/20 0.43
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
HSP90AA1 P07900 1/20 0.37
IDO1 P14902 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KDM5A P29375 1/20 0.37
EP300 Q09472 1/20 0.34
KAT2B Q92831 1/20 0.34
KAT8 Q9H7Z6 1/20 0.34
MAOA P21397 2/20 0.33
CYP17A1 P05093 1/20 0.33
CYP19A1 P11511 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
MGAM O43451 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2559970 0.80 IDO1 (0.39) ERN1KDM4EIDO1CYP17A1CYP19A1
SCHEMBL4737860 0.79 KDM5A (0.59) KDM4EMEN1NPC1HSP90AA1IDO1
SCHEMBL2556489 0.77 CYP19A1 (0.40) KDM4EMEN1KMT2ANPSR1CYP19A1
SCHEMBL2556065 0.77 PDE4B (0.43) IDO1CYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL2559729 0.76 CCNC (0.44) NPC1RAB9A
SCHEMBL2559731 0.76 CCNC (0.44) NPC1RAB9A
SCHEMBL29890504 0.72 ERN1 (0.53) ERN1KDM4EMEN1NPC1HSP90AA1
SCHEMBL26933519 0.72 ERN1 (0.53) ERN1KDM4EMEN1NPC1HSP90AA1
SCHEMBL2795791 0.69 KDM5A (0.38) ERN1KDM4EMEN1NPC1HSP90AA1
SCHEMBL2556718 0.69 CYP17A1 (0.39) ERN1KDM4ENPC1RAB9AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed